Introduction {#Sec1}
============

Voltage-gated sodium channels (Na~V~) are crucial in excitable as well as non-excitable cells and mutations in Na~V~1.x-subunits have been associated with muscular, neuronal and cardiac channelopathies in human^[@CR1]^. Voltage-gated potassium (K~V~) channels and prokaryotic Na~V~ channels are tetramers of subunits containing six transmembrane segments (S1 to S6). Each of the four subunits consists of one voltage-sensor domain (S1 to S4) and a pore domain (S5-S6). The four pore domains tetramerize to form a single pore module, which is regulated by the four voltage sensor domains. The arrangement of eukaryotic Na~V~ channels is similar, with one major difference: the channel is made of a single subunit containing four homologous domains, rather than four identical subunits. Each domain in eukaryotic Na~V~ channels is structurally equivalent to one subunit in K~V~ or prokaryotic Na~V~ channels, and consists of six transmembrane segments (S1 to S6).

Despite intensive work on the voltage-gating of K~V~ and Na~V~ channels, we still lack a clear picture describing the coupling between S4 voltage-sensor movement and S6 pore gating. Both structural and functional studies identified the linker between S4 and S5 (named S4-S5~L~) and the C-terminus of S6 (named S6~T~), as major actors in this coupling^[@CR2]--[@CR21]^. Different coupling mechanisms have been suggested. The crystal structure of K~V~1.2, and more recently the cryo-electron microscopy and crystal structures of both eukaryotic and prokaryotic Na~V~ channels suggested that the four S4-S5~L~ form a mechanical lever or a constriction ring intimately interacting with S6~T~ when the activation gate is closed. Upon membrane depolarization, constriction is relieved, and channel activation gate can open^[@CR10],[@CR12],[@CR15],[@CR19]--[@CR21]^. On the other hand, other studies performed on the bacterial Na~V~Ms (from Magnetococcus marinus) channel suggest that the S4-S5~L~ may also be involved in an interaction motif stabilizing the channel open state^[@CR8],[@CR16],[@CR17]^. So rather than only playing the role of a constriction ring (obligatory role, as described for Shaker^[@CR22]^), S4-S5~L~ may also allosterically modulate channel gating: the "up" or activated S4 conformation would favor but not impose the channel open state. Such allosteric regulation has been suggested for several channels, including hK~V~11.1 (hERG) and hK~V~7.1 (KCNQ1) channels^[@CR23],[@CR24]^. In these channels, we elucidated the nature of this allosteric coupling: when S4 sensors are in the "down" or deactivated conformation, the four S4-S5~L~ bind to S6~T~ in the closed state, stabilizing this state^[@CR25],[@CR26]^. Noteworthy, ATP has also been shown to stabilize the closed state of K~ATP~ channels^[@CR27],[@CR28]^. In K~V~ channels, S4-S5~L~ can thus be seen as an inhibitor (like ATP) attached to the S4 voltage sensor. When the membrane is depolarized, S4 pulls S4-S5~L~ out of its binding pocket, leading to channel opening. This is consistent with the observation that specific S4-S5~L~-mimicking peptides inhibit hK~V~7.1 and hK~V~11.1 channels, by replacing the endogenous segment in the binding pocket^[@CR25],[@CR26]^. This mechanism was recently extended to hK~V~10.2 channels^[@CR29]^.

In the case of Na~V~ channels, such an allosteric model of the voltage-dependent gating mechanism has never been functionally tested. From the interaction motif observed in Na~V~Ms channel^[@CR8],[@CR16],[@CR17]^, we hypothesized that S4-S5~L~ acts as a ligand binding to S6~T~ and stabilizing the channel open-state and not the closed state. We used the same peptide approach previously used for hK~V~7.1, hK~V~11.1 and hK~V~10.2 channels^[@CR25],[@CR26],[@CR29]^ to test whether S4-S5~L~ peptides lead to a gain of function in both prokaryotic and eukaryotic Na~V~ channels.

We designed three S4-S5~L~ mimicking peptides specific for prokaryotic Na~V~Sp1 (from Silicibacter pomeroyi), and three S4-S5~L~ mimicking peptides specific for each of the four domains of hNa~V~1.4. None of these S4-S5~L~ peptides had an inhibitory effect. One S4-S5~L~ peptide from Na~V~Sp1 and at least one S4-S5~L~ peptide from DI, DII and DIII domains of hNa~V~1.4 promoted channel activity. Our results suggest that, as demonstrated in three K~V~ channels, the ligand/receptor model of interaction between S4-S5~L~ and S6~T~ applies also to both Na~V~Sp1 and hNa~V~1.4 channels, with one major difference: S4-S5~L~ stabilizes the open state in Na~V~ channels.

Results {#Sec2}
=======

A specific S4-S5~L~ mimicking peptide activates the bacterial channel Na~V~Sp1 {#Sec3}
------------------------------------------------------------------------------

First, we tested the ligand/receptor model on Na~V~Sp1, a bacterial channel that is organized as a tetramer of identical subunits. If endogenous S4-S5~L~ acts like a ligand that stabilizes the activation gate in the open state, then a peptide mimicking endogenous S4-S5~L~ should increase Na~V~Sp1 channel activity (Fig. [1A](#Fig1){ref-type="fig"}). Three peptides were designed. One peptide, S4-S5~L~(−3), is aligned with the active peptides for hK~V~7.1^[@CR25]^ and hK~V~11.1^[@CR26]^ channel (Fig. [1B](#Fig1){ref-type="fig"}). Noteworthy, this peptide includes the sequence that aligns with Na~V~Ms RRVVQ motif. This RRVVQ motif engages a series of salt bridge and hydrogen-bonded interactions with S6~T~ and S3, such interactions playing a major role in channel open state stabilization^[@CR16]^. Two other Na~V~Sp1 peptides, S4-S5~L~(0) and S4-S5~L~(+3) lack this sequence. Each Na~V~Sp1 peptide, S4-S5~L~(−3), S4-S5~L~(0) or S4-S5~L~(+3), was functionally tested separately. One peptide-encoding plasmid was co-transfected with the Na~V~Sp1-encoding plasmid. Results were compared to those from reference cells, co-transfected with Na~V~Sp1 and an unrelated peptide (hK~V~11.1 S6 C-terminal part, I663-T675, Control 1). An additional negative control, also unrelated to Na~V~ channels (hK~V~11.1 S4-S5~L~, A536-F551, Control 2) was used to confirm the absence of the Control 1 peptide effect. In all the following experiments, Control 2 did not show any significant difference, when compared to Control 1.Figure 1Ligand/receptor model. Multiple alignment used to design Na~V~Sp1 and Na~V~1.4 S4-S5~L~ peptides. (**A**) scheme of the ligand/receptor model in which S4-S5~L~ (endogenous segment, deep blue) binds to S6~T~ (endogenous segment, light blue) to stabilize the channel in the open state, as suggested by works on Na~V~Ms channel. The S4-S5~L~ peptide (red) mimics endogenous S4-S5~L~, stabilizing the channel open conformation. (**B)** Multiple alignment used to design Na~V~Sp1 and hNa~V~1.4 peptides from previously potent hK~V~7.1 and hK~V~11.1 S4-S5~L~ peptides (framed). Starting from S4-S5~L~(−3) peptide, two others peptides were designed, by shifting toward the C-terminus by 3 (S4-S5~L~(0)) and 6 amino acids (S4-S5~L~(+3)). Red: basic residues, yellow: acidic residues. Colored boxes represent the S4 and S5 segments. Mutated residues in skeletal channelopathies are underlined (in Na~V~1.4 S4-S5~L~). Arrows point to Na~V~Ms-corresponding residues interacting with S6~T~ (text) **C**: Scheme of the hNa~V~1.4 and Na~V~Sp1 channels showing the color used for each peptide/domain.

When co-expressed with Na~V~Sp1, the S4-S5~L~(−3) peptide provoked a gain of function on the current density (Fig. [2](#Fig2){ref-type="fig"}, Supplemental Table [1](#MOESM1){ref-type="media"}). Moreover, the activation curve was shifted to more negative potential with no concurrent shift of the voltage-dependence of the activation/inactivation kinetics. This latter observation excludes a membrane charge screening, locally changing the potential detected by the voltage-sensor (Supplemental Fig. [1](#MOESM1){ref-type="media"}). It is possible that enhancement of the Na~V~Sp1 current density of Na~V~Sp1 at 30 mV stimuli is partially caused by the negative shift of voltage dependent activation. Since a gain of function may also lead to incomplete channel deactivation^[@CR25]^, we also tested if the current measured at −90mV, in the presence of S4-S5~L~ peptides, was greater than in ctrl1 and ctrl2 conditions. Our data shows that this is not the case (Supplemental Fig. [2](#MOESM1){ref-type="media"}), suggesting that channel deactivation is complete in the presence of peptides. The other two peptides, S4-S5~L~(0) and S4-S5~L~(+3) lacking the sequence aligning to the Na~V~Ms RRVVQ motif had no effect. The gain of function, caused by Na~V~Sp1 S4-S5~L~(−3) peptide suggests that Na~V~Sp1 follows a ligand/receptor model of voltage-dependent gating, with S4-S5~L~ stabilizing the channel in the open state.Figure 2Effect of Na~V~Sp1 S4-S5~L~ mimicking peptides on Na~V~Sp1 current density and activation curve. (**A**) representative, superimposed current recordings in COS-7 cells transfected with Na~V~Sp1 and control 1 (top trace) or S4-S5~L~(−3) peptide (bottom trace). Inset: activation voltage protocol used (holding potential: −90 mV; 300-ms pulse at the indicated potentials; one sweep every 5 s). (**B)** Dot plot and mean ± sem of peak Na~V~Sp1 current densities recorded in COS-7 cells co-transfected with Na~V~Sp1 and the indicated peptide, at 30 mV. (**C)** Relative peak conductance *versus* membrane potential curves for Na~V~Sp1 channels in COS-7 cells co-transfected with Na~V~Sp1 and the indicated peptide. Lines are Boltzmann fits to the data. (**D,E)** Dot plot and mean ± sem of Na~V~Sp1 half-activation potential (V~0.5~; **D**) and activation slope (K; **E**) in COS-7 cells co-transfected with Na~V~Sp1 and the indicated peptide. \*p value *vs*. both controls \<0.05.

Because the active peptide S4-S5~L~(−3) contains two arginines (R116 and R117) that are absent in the inactive peptides (S4-S5~L~(0) and S4-S5~L~(+3)), we tested the role of these positively charged residues in Na~V~Sp1 gating. Charged amino-acid distribution in S4-S5~L~ and S6~T~ is quite different between Na~V~Sp1 and Na~V~Ms, with an additional arginine at the start of Na~V~Sp1 S4-S5~L~ (R114, before R116 and R117, cf. black arrows pointing to R in Supplemental Fig. [3](#MOESM1){ref-type="media"}) and an additional aspartate at position 222 in S6~T~ (black arrow pointing to D in Supplemental Fig. 3). In order to test the potential contribution of R114, R116 and R117 to the stabilization of the open state, we mutated one by one each arginine to an aspartate carrying the opposite charge. R114D did not have any effect on channel activity (Fig. [3A--B,E](#Fig3){ref-type="fig"}), but both R116D and R117D led to nonfunctional channels (Fig. [3A,C--D](#Fig3){ref-type="fig"}), consistent with a major role of both arginines in Na~V~Sp1 open state stabilization by both the endogenous and exogenous peptides. But because of the absence of detectable current, we could not exclude that R116D and R117D were preventing channel trafficking to the membrane. In order to confirm electrostatic interaction between S4-S5~L~ and S6~T~ to stabilize Na~V~Sp1 open state, we had to identify residues in S6~T~ with which R116 and/or R117 interacts. D222 was, among other residues, a good candidate because it is in a region that aligns with Na~V~Ms residues interacting with S4-S5~L~ to stabilize the channel open state (Supplemental Fig. [3](#MOESM1){ref-type="media"}). Interestingly, the addition of the D222R mutation on top of the nonfunctional R116D mutant was not only able to restore channel activity but also led to a channel that is more prone to be open, as compared to when both amino acids at position 116 and 222 carry a positive charge (D222R): we observed an increase in current amplitude and a −20-mV shift in the activation curve (Fig. [4](#Fig4){ref-type="fig"}). Such activity restoration and gain of function when amino acids at position 116 and 222 carry opposite charges (R116D + D222R) suggest that both endogenous and exogenous S4-S5~L~ peptides stabilize the channel open state through specific S4-S5~L~ and S6~T~ interaction.Figure 3Effect of charge reversal in amino acids present in Na~V~Sp1 S4-S5~L~(−3) activating peptide on Na~V~Sp1 current density and activation curve. (**A**) representative, superimposed recordings of WT and mutant Na~V~Sp1 current. Activation voltage protocol used is the same as in Fig. [2](#Fig2){ref-type="fig"}. (**B--D)** Dot plot and mean ± sem of peak current densities recorded in COS-7 cells transfected with WT or mutant Na~V~Sp1, at 30 mV. (**E)** Relative peak conductance *versus* membrane potential curves for WT or mutant Na~V~Sp1 channels transfected in COS-7. Lines are Boltzmann fits to the data. \*\*\*p value *vs*. WT \< 0.001.Figure 4Opposite charges at position 116 (Na~V~Sp1 S4-S5~L~) and 222 (Na~V~Sp1 S6~T~) stabilizes the Na~V~Sp1 channel open state. (**A**) representative, superimposed current recordings of single Na~V~Sp1 mutant D222R and double mutant D222R/R116D. Activation voltage protocol used is the same as in Fig. [2](#Fig2){ref-type="fig"}. (**B)** Dot plot and mean ± sem of peak current densities recorded in COS-7 cells transfected with D222R or D222R/R116D Na~V~Sp1, at 30 mV. (**C)** Relative peak conductance *versus* membrane potential curves for D222R or D222R/R116D Na~V~Sp1 channels transfected in COS-7 cells. Lines are Boltzmann fits to the data. (**D**,**E)** Dot plot and mean ± sem of Na~V~Sp1 half-activation potential (V~0.5~; **D**) and activation slope (K; **E**) in COS-7 cells transfected with D222R or D222R/R116D Na~V~Sp1. \*\*\*p value *vs*. D222R \< 0.001.

hNa~V~1.4 S4-S5~L~ peptides activate hNa~V~1.4 {#Sec4}
----------------------------------------------

We also tested the ligand/receptor model on the hNa~V~1.4 voltage-gated channel that is organized as a single subunit of four homologous domains^[@CR11],[@CR15],[@CR20],[@CR21]^. Again, three S4-S5~L~-encoding plasmids were designed for each domain, based on sequence alignment with hK~V~7.1 and hK~V~11.1 (Fig. [1B](#Fig1){ref-type="fig"}). Each of the 12 designed S4-S5~L~ peptides was tested separately: each hNa~V~1.4 S4-S5~L~ peptide-encoding plasmid was co-transfected with hNa~V~1.4 and hNa~V~β1-encoding plasmids.

Among the 12 tested hNa~V~1.4 S4-S5~L~ peptides, three peptides increased the hNa~V~1.4 current density. These activating peptides mimic three of the four hNa~V~1.4 S4-S5 linkers, in domain I (S4-S5~L~(+3)), domain II (S4-S5~L~(+3)) and domain III (S4-S5~L~(0)) of hNa~V~1.4 (Figs. [5B](#Fig5){ref-type="fig"}--[8B](#Fig8){ref-type="fig"}, Supplemental Table [2](#MOESM1){ref-type="media"}).Figure 5Effect of Na~V~1.4 S4-S5~L~ mimicking peptides of domain I on Na~V~1.4 current density and activation curve. (**A**) representative, superimposed current recordings in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and control 1 (top trace) or domain I S4-S5~L~(+3) peptide (bottom trace). Inset: activation voltage protocol used (holding potential: −100 mV; 30-ms pulse; one sweep every 2 s). (**B)** Dot plot and mean ± sem of peak Na~V~1.4 current densities recorded in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and the indicated peptide, at 0 mV. **C:** Relative peak conductance *versus* membrane potential curves for Na~V~1.4 channels in the same cell groups as in (**B)**. Lines are Boltzmann fits to the data. (**D**,**E)** Dot plot and mean ± sem of Na~V~1.4 half-activation potential (V~0.5~; **D**) and activation slope (K; **E**) in the same cells group as in (**B)**. \*p value *vs*. both controls \<0.05.Figure 6Effect of Na~V~1.4 S4-S5~L~ mimicking peptides of domain II on Na~V~1.4 current density and activation curve. (**A**) representative, superimposed current recordings in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and control 1 (top trace) or domain II S4-S5~L~(+3) peptide (bottom trace). Inset: activation voltage protocol used (holding potential: −100 mV; 30-ms pulse; one sweep every 2 s). (**B)** Dot plot and mean ± sem of peak Na~V~1.4 current densities recorded in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and the indicated peptide, at 0 mV. (**C**) Relative peak conductance *versus* membrane potential curves for Na~V~1.4 channels in the same cell groups as in (**B)**. Lines are Boltzmann fits to the data. (**D**,**E)** Dot plot and mean ± sem of Na~V~1.4 half-activation potential (V~0.5~; **D**) and activation slope (K; **E**) in the same cells group as in (**B)**. \*p value *vs*. both controls \<0.05.Figure 7Effect of Na~V~1.4 S4-S5~L~ mimicking peptides of domain III on Na~V~1.4 current density and activation curve. (**A**) representative, superimposed current recordings in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and control 1 (top trace) or domain III S4-S5~L~(0) peptide (bottom trace). Inset: activation voltage protocol used (holding potential: −100 mV; 30-ms pulse; one sweep every 2 s). (**B)** Dot plot and mean ± sem of peak Na~V~1.4 current densities recorded in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and the indicated peptide, at 0 mV. **C:** Relative peak conductance *versus* membrane potential curves for Na~V~1.4 channels in the same cell groups as in (**B)**. Lines are Boltzmann fits to the data. (**D**,**E)** Dot plot and mean ± sem of Na~V~1.4 half-activation potential (V~0.5~; **D**) and activation slope (K; **E**) in the same cells group as in (**B)**. \*p value *vs*. both controls \<0.05. \*\*p value *vs*. both controls \<0.01.Figure 8Effect of Na~V~1.4 S4-S5~L~ mimicking peptides of domain IV on Na~V~1.4 current density and activation curve. (**A**) representative, superimposed current recordings in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and control 1 (top trace) or domain IV S4-S5~L~(+3) peptide (bottom trace). Inset: activation voltage protocol used (holding potential: −100 mV; 30-ms pulse; one sweep every 2 s). (**B**) Dot plot and mean ± sem of peak Na~V~1.4 current densities recorded in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and the indicated peptide, at 0 mV. (**C**) Relative peak conductance *versus* membrane potential curves for Na~V~1.4 channels in the same cell groups as in (**B**). Lines are Boltzmann fits to the data. (**D**,**E**) Dot plot and mean ± sem of Na~V~1.4 half-activation potential (V~0.5~; **D**) and activation slope (K; **E**) in the same cells group as in (**B**).

One additional peptide in domain III shifted the activation curve to more negative potentials (S4-S5~L~(−3), Supplemental Table [2](#MOESM1){ref-type="media"}; Fig. [7C--E](#Fig7){ref-type="fig"}), also leading to a gain of function. This S4-S5~L~(−3) peptide is different from the S4-S5~L~(0) peptide that increased the current density in the same domain: it is shifted by three amino acids toward the N-terminus. We did not observe any alteration of the activation/inactivation kinetics by any of the peptides (Supplemental Fig. [4](#MOESM1){ref-type="media"}).

S4-S5~L~ peptides do not modify hNa~V~1.4 channel trafficking {#Sec5}
-------------------------------------------------------------

Cell surface biotinylation experiments were performed in order to verify whether increased current densities were due to gating alteration or to an increased channel trafficking. These experiments were done using the three peptides in domain I, II, III of hNa~V~1.4 that were causing an increase in current density, and using the S4-S5~L~(+3) peptide in domain IV of hNa~V~1.4 that was showing a trend of increased current density, although not significant. Neither the total nor the biotinylated fraction (plasma membrane) of hNa~V~1.4 protein was increased by any of the peptides, suggesting that domain I S4-S5~L~(+3), domain II S4-S5~L~(+3) and domain III S4-S5~L~(0) peptides increase hNa~V~1.4 current density through an alteration of channel gating and not its trafficking (Fig. [9](#Fig9){ref-type="fig"}; Supplemental Fig. [5](#MOESM1){ref-type="media"}).Figure 9Effect on Na~V~1.4 channel expression of S4-S5~L~ mimicking peptides associated with an increased current density. Left: (**A**,**C)** representative western blots of total Na~V~1.4, transferrin receptor (TransR) and GAPDH from transfected COS-7 cells, in the presence of various control and S4-S5~L~ peptides as indicated. (**B**,**D)** representative western blots of the cell surface fraction of Na~V~1.4, transferrin receptor (TransR) and GAPDH from transfected COS-7 cells, in the presence of various control and S4-S5~L~ peptides. Right: corresponding quantifications of normalized mean ± sem intensities. Band intensities are first normalized to the intensity of the corresponding TransR bands, and ratios are then normalized to control 1 condition. In all condition, p \> 0.05. In A--D, the three blots, realized on the same membrane, are cropped. Full-length blots of each tested protein are reported in Supplemental Fig. [5](#MOESM1){ref-type="media"}.

Thus, out of the 12 tested peptides, four led to a gain of function of hNa~V~1.4 channel through an effect on channel gating.

Effects of combination of peptides {#Sec6}
----------------------------------

Since in hNa~V~1.4 the S4-S5 linker sequences of the four domains differ, we explored if co-transfecting two activating peptides exerts a stronger effect on hNa~V~1.4 current density than the individual peptides, as two domains will be stabilized open instead of only one. In order to keep the same expression level of the channel, we needed to keep the same total DNA quantity in all conditions. Thus, to combine two peptides we added half quantity of each peptide-encoding plasmid, as compared to conditions with only one peptide. We did not observe any increase in current density when DI-S4-S5~L~(+3) and DII-S4-S5~L~(+3) peptides were co-expressed. This observation suggests that combination of the two peptides in lesser quantity was not as potent as when only one peptide was expressed (Fig. [10](#Fig10){ref-type="fig"}). It is possible that the presence of (i) smaller quantity of peptides in addition to (ii) some steric hindrance prevent the activating effect. Noteworthy, domains I and II are adjacent, consistent with the hypothetical steric hindrance. To limit the effect of steric hindrance, we selected activating peptides from two non-adjacent domains, namely DI-S4-S5~L~(+3) and DIII-S4-S5~L~(0). Indeed, co-expression of these DI-S4-S5~L~(+3) and DIII-S4-S5~L~(0) peptides caused an increase in the hNa~V~1.4 current density. Such an increase was similar but not greater than when only one peptide was expressed, probably because each of the peptides was present in lesser quantity. This observation highlights a limit of the model in which S4-S5 effects are not strong enough to potentially quantify the synergistic effect of the combination of peptides.Figure 10Effect of combination of two Na~V~1.4 S4-S5~L~ mimicking peptides that both had an effect on Na~V~1.4 current density when expressed alone. (**A**) representative, superimposed current recordings in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and control 1 (top trace) or the combination of domain I S4-S5~L~(+3) peptide and domain III S4-S5~L~(0) peptide (bottom trace). Inset: activation voltage protocol used (holding potential: −100 mV; 30-ms pulse; one sweep every 2 s). (**B)** Dot plot and mean ± sem of peak Na~V~1.4 current densities recorded in COS-7 cells co-transfected with Na~V~1.4, Na~V~ß1, and the indicated peptides, at 0 mV. **C**: Relative peak conductance *versus* membrane potential curves for Na~V~1.4 channels in the same cell groups as in (**B)**. Lines are Boltzmann fits to the data. (**D**,**E**) Dot plot and mean ± sem of Na~V~1.4 half-activation potential (V~0.5~; **D**) and activation slope (K; **E**) in the same cells group as in (**B)**. \*p value *vs*. both controls \<0.05.

S4-S5~L~ peptides modify hNa~V~1.4 channel inactivation {#Sec7}
-------------------------------------------------------

Since mutations in domains I, III and IV S4-S5~L~ have been associated with a large modification of the Na~V~1.4 channel fast inactivation^[@CR30]--[@CR32]^, we also tested the effect of the peptides on channel inactivation. We observed an increase in the slope factor of the inactivation curve when DI-S4-S5~L~(+3) or DIII-S4-S5~L~(+3) peptide was expressed (Supplemental Figs. [6](#MOESM1){ref-type="media"}--[9](#MOESM1){ref-type="media"}; Supplemental Table [2](#MOESM1){ref-type="media"}). Also, and consistent with the effect of the combination of peptides on the activation curve, effect of DI-S4-S5~L~(+3) was still observed when it was co-expressed with the peptide corresponding to the non-adjacent domain (III), but not with the peptide corresponding to the adjacent domain (II) (Supplemental Fig. [10](#MOESM1){ref-type="media"}).

Discussion {#Sec8}
==========

In this work, we used a S4-S5~L~ mimicking peptide approach to test whether voltage-gated sodium channels follow the ligand/receptor model previously proposed for hK~V~7.1^[@CR25]^, hK~V~11.1^[@CR26]^ and hK~V~10.2^[@CR29]^ channels. We identified one activating S4-S5~L~ peptide in Na~V~Sp1 and four in hNa~V~1.4, suggesting that Na~V~ channels follow a ligand/receptor model of voltage-dependent gating (Fig. [11c](#Fig11){ref-type="fig"}): when the membrane is depolarized, endogenous S4-S5~L~ stabilizes the open state of Na~V~ channels, as indicated by the Na~V~Ms structure captured in the open state^[@CR8],[@CR16],[@CR17]^. This contrasts with what is happening with K~V~ channels: when the membrane is polarized, endogenous S4-S5~L~ stabilizes the closed state of K~V~ channels, as suggested by several studies^[@CR25],[@CR26],[@CR29]^.Figure 11Summarizing schemes. (**a,b**) Two mechanisms of voltage-dependent gating. (**a**) The gating ring model in which the four S4-S5~L~ (endogenous segments, deep blue, only two are shown) constitute a constriction ring preventing S6 (endogenous segment, light blue) iris-like dilation. (**b**) Scheme of the ligand/receptor model in which S4-S5~L~ binds to S6~T~ to stabilize the channel in the open state. (**c)** The S4-S5~L~ peptides (red) mimic the effect of endogenous S4-S5~L~ described in (b), stabilizing the open conformation. (**d**) Alternatively, the S4-S5~L~ peptides (red), interact with endogenous S4-S5~L~, destabilizing the gating ring described in (a) and hence lead to channel opening.

The various peptide effects, either on current density or on the activation voltage dependence, suggest that peptides are acting on different conformational transitions leading to channel opening. Due to the multi-state process of channel voltage-dependent gating, implying several conformational changes, peptides affinity may be high enough for the alteration of one parameter (e.g., current density), but not for the alteration of the other one (e.g., V~0.5~, slope factor). The peptides effects on current density but not on the activation voltage dependence have already been observed in hK~V~11.1 channel^[@CR26]^ and hK~V~7.1 channels^[@CR25]^ and were also described in a kinetic model of the peptide effect on K~V~10.2 channels^[@CR29]^. In hK~V~11.1 channel, we show that a S6~T~ mimicking peptide has only an effect on the current density when affinity is low but can also drastically change the activation curve when its affinity is increased by a specific disulfide bridge^[@CR26]^.

Here, all the data obtained on hNa~V~1.4 suggest that S4-S5~L~ in domain I, II and III play a significant role in the channel voltage dependence of activation. In the neuronal channel Na~V~1.2, mutations of S4 gating charges in all four domains were found to affect the activation^[@CR33]^. Nevertheless, of the mutations that shifted the V~0.5~ of activation, the most pronounced effects were observed when the fourth charge in each of domains I, II, and III was neutralized. This suggests that domains I to III play a critical role in coupling the voltage sensor with the activation gate of Na~V~1.2, consistent with our results on hNa~V~1.4. Moreover, voltage-clamp fluorimetry experiments performed on Na~V~1.4 S4 segments showed that domain I, II and III play a significant role in the channel voltage-dependence of activation, also consistent with our results on hNa~V~1.4^[@CR34]^.

Although consistent with a ligand/receptor model, S4-S5~L~ peptides effects on Na~V~Sp1 and hNa~V~1.4 are moderate. It is worth mentioning that these effects are nevertheless in the range of those observed in previous studies on three different voltage-gated potassium channels^[@CR25],[@CR26],[@CR29]^. In the previous studies, we interpreted that the S4-S5~L~/S6~T~ interaction has to be loose, probably due to the low affinity between native S4-S5~L~ and S6~T~, which is necessary for S4-S5~L~ ligand unbinding and channel opening during membrane depolarization^[@CR26]^. In the channel, this low affinity is compensated by the imposed proximity of the two segments. Experimentally, this can be compensated only partly by high peptide concentration. In two K~V~ channels, we found a way to reinforce S4-S5~L~ peptide binding to S6~T~ via a specific disulfide bridge between two cysteines, and hence, increase their effects on the channel^[@CR26],[@CR29]^. It would be interesting to identify such a pair of cysteines in Na~V~ channels.

Because of the moderate peptides effects, we cannot be sure that the ligand/receptor is the major actor of signal transduction between S4 movement and pore opening in Na~V~ channels. Other mechanisms such as the constriction ring mechanism, suggested by several Na~V~ channels structures, certainly play a major role^[@CR10],[@CR12],[@CR15],[@CR20],[@CR21]^. The S4-S5~L~ peptides may also disrupt the constriction ring and by this way lead to channel opening (Fig. [11d](#Fig11){ref-type="fig"}). But the fact that Na~V~Sp1 most potent peptides contain amino-acids that play a major role in channel open state stabilization (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}), strongly supports the hypothesis that these peptides (endogenous or exogenous peptides) bind to the C-terminal end of S6 and stabilize the channel open state (Fig. [11c](#Fig11){ref-type="fig"}).

Both mechanisms (Constriction ring in Fig. [11a](#Fig11){ref-type="fig"} and ligand-receptor in Fig. [11b](#Fig11){ref-type="fig"}) may coexist: the interaction between S4-S5~L~ and S6~T~ suggested in the closed state (recent work of Wisedchaisri *et al*. on the bacterial channel Na~V~Ab^[@CR19]^) may completely reconfigure in the open state (studies on NavMs^[@CR8],[@CR16],[@CR17]^, and also the present study on Na~V~Sp1 and Na~V~1.4). Interestingly, S4-S5~L~ residues implicated in the interaction with S6~T~ in the Na~V~Ab closed state (highlighted in Supplemental Fig. [3](#MOESM1){ref-type="media"}) do not align with the S4-S5~L~ residues implicated in the interaction with S6~T~ in the Na~V~Ms open state, suggesting the aforementioned reconfiguration of the interaction between S4-S5 linker and S6~T~. In addition, effects may be moderate because the fast kinetics of Na~V~ channel do not give the S4-S5~L~ peptides enough time to outcompete the endogenous S4-S5~L~ from interacting with S6~T~.

Regarding peptides effect on hNa~V~1.4, we took the option to co-express the pore-forming subunit with the auxiliary subunit hNa~V~ß1 to be closer to physiological conditions. Because of the presence of hNa~V~ß1, we cannot exclude that peptides effects on hNa~V~1.4 are mediated by this subunit. However, (i) the similitude of the peptide effects independently of the domain (I, II or III), (ii) the absence of domain IV peptide effect and (iii) the similitude of hNa~V~1.4 results to those observed on Na~V~Sp1 channel, lacking auxiliary subunit, suggest that the effect is rather specific to the pore-forming subunit.

From the present and previous studies, it seems that the coupling between voltage sensor movement and pore gating falls into two categories:the mechanical lever model: an obligatory coupling in which S4 resting state directly translates into S6 gate closed state. This obligatory coupling may be described as a simple mechanical work. At rest, S4-S5 linker helices compress the S6 helices and maintain the pore closed. Upon membrane depolarization, an outward displacement of S4 relieves the compression, allowing pore opening^[@CR10]^. This model of electromechanical coupling is likely for Shaker-like channels in which open probability is very close to zero at hyperpolarizing potentials^[@CR22]^;the ligand/receptor model: the obligatory coupling cannot hold if the S6 gate is able to open, even if S4 segments are in the resting state, as shown for hK~V~11.1 and hK~V~7.1 channels^[@CR23],[@CR24],[@CR35]^. In this case, coupling is allosteric rather than obligatory: in these K~V~ channels, S4 resting state favors rather than forces channel closing. This allosteric coupling is realized through a ligand/receptor mechanism between S4-S5~L~ and S6~T~ in hK~V~7.1, hK~V~11.1 and hK~V~10.2 channels^[@CR25],[@CR26],[@CR29]^. At rest, S4-S5~L~ binds to S6~T~ and stabilizes the channel in a closed state. If S4-S5~L~ affinity to S6~T~ is low enough, S4-S5~L~ and S6~T~ interaction is not permanent in S4 resting state, allowing transient pore opening. This is consistent with mutations in S4-S5~L~ and S6~T~ increasing the fraction of constitutively active current^[@CR9],[@CR23],[@CR35],[@CR36]^.

Together, structural studies and the present study suggest that Na~V~ channels combine both mechanical lever (obligatory) and ligand/receptor (allosteric) models: (i) Structural data of various Na~V~ channel point to an electromechanical (obligatory) coupling model in which the four S4-S5 linkers are organized in a constriction ring that forces the channel gate to close when membrane is polarized. Upon membrane depolarization, movement of the S4 induces a lateral dilation of the S4--S5 linker, leading to a rotation and bending of the pore-lining S6 segments, which ultimately open the activation gate^[@CR10],[@CR12],[@CR15],[@CR20],[@CR21],[@CR37]^. (ii) The present study, associated with studies on Na~V~Ms^[@CR8],[@CR16],[@CR17]^, suggests an allosteric coupling: when S4 segments are in the activated conformation, S4-S5 linkers bind to S6~T~ and stabilize the channel in the open state. Various Na~V~1.4 structures, all showing S4 in the activated state but showing the S6 gate either closed^[@CR15]^ or open^[@CR11],[@CR21]^, are consistent with this allosteric mechanism in which S4, when activated, is not strongly coupled to S6~T~, but rather develop interactions with S6~T~ favoring the channel open state.

Many mutations of the hNa~V~1.4-encoding gene, *SCN4A*, are linked to muscular channelopathies^[@CR38]^. The role of the S4-S5 linker as a modulator of the channel open state is consistent with the identification of several mutations in the area corresponding to the activating peptides: L689F, I692M, I693T in domain II and V1149L, A1152D and P1158S in domain III (underlined in Fig. [1B](#Fig1){ref-type="fig"}). Noteworthy, mutations in and around these sites (L689F, I692M, N1151C, A1152C, A1160C, P1158S) impair activation kinetics^[@CR39]--[@CR45]^.

Finally, mimicking peptides engineered for hK~V~7.1, hK~V~11.1, hK~V~10.2 and now hNa~V~1.4 may lead to a new therapeutic strategy for cardiac, neuronal and muscular channelopathies^[@CR46]^.

Methods {#Sec9}
=======

Similar methods have been used in previous studies^[@CR25],[@CR26],[@CR29]^.

Plasmid constructs {#Sec10}
------------------

For Na~V~Sp1 and hNa~V~1.4, S4-S5~L~ plasmids were designed from the alignment with hK~V~11.1 and hK~V~7.1 S4-S5~L~ peptides. First, multiple-sequence alignment was realized with Cobalt^[@CR47]^. This program aligned the predicted/observed S4 and S5 transmembrane domains of hK~V~11.1 (Uniprot Q12809), hK~V~7.1 (P51787), Na~V~Sp1^[@CR14],[@CR48]^, and the four domains of hNa~V~1.4 (Uniprot P35499). We designed a Na~V~Sp1 S4-S5~L~ peptide and also a Na~V~1.4 S4-S5~L~ peptide in each domain, based on the aligned most potent hK~V~7.1 and hK~V~11.1 S4-S5~L~ peptides, as shown in Fig. [1B](#Fig1){ref-type="fig"}^[@CR25],[@CR26]^. Since a peptide shifted by three amino acids toward the C-terminus also inhibited hK~V~7.1 (L251-L266), we also selected the corresponding peptide and also the next one in case of slight differences in binding sites. Thus, for Na~V~Sp1 and each hNa~V~1.4 domain, three different S4-S5~L~ plasmids were designed. All the peptides had the same length (16 amino-acids). Names of the peptides were given according to their position along the sequence: S4-S5~L~ (−3), S4-S5~L~ (0), and S4-S5~L~ (+3) (Fig. [1B](#Fig1){ref-type="fig"}). Two peptides, corresponding to hKv11.1 S4-S5 linker (A536-F551) and hKv11.1 C-terminus of S6 (I663-T675) were used as two negative controls. Oligonucleotides encoding hNa~V~1.4 and Na~V~Sp1 peptides were synthesized by TOP Gene Technologies and contained a XhoI restriction enzyme, a methionine (ATG) for translation initiation, and a glycine (GGA) to protect the ribosome binding site during translation and the nascent peptide against proteolytic degradation^[@CR49]^. A BamHI restriction enzyme site was synthesized at the 3′ end immediately following the translational stop codon (TGA). These oligonucleotides were then cloned into pIRES2-EGFP (Clontech) and sequenced. Mutant Na~V~Sp1 were generated by using the QuikChange site-directed mutagenesis kit (Stratagene).

Cell culture and transfection {#Sec11}
-----------------------------

The African green monkey kidney-derived cell line, COS-7, was obtained from the American Type Culture Collection (CRL-1651) and cultured in Dulbecco's modified Eagle's medium (GIBCO) supplemented with 10% fetal calf serum and antibiotics (100 IU/ml penicillin and 100 µg/ml streptomycin) at 5% CO~2~ and 95% air, maintained at 37 °C in a humidified incubator. Cells were transfected in 35-mm Petri dishes when the culture reached 50--60% confluence, with DNA (2 µg total DNA) complexed with FuGENE-6 (Roche Molecular Biochemical) according to the standard protocol recommended by the manufacturer. For hNa~V~1.4 experiments, COS-7 cells were co-transfected with 0.4 µg pRC-hNa~V~1.4, 0.4 µg pRC-hNa~V~ß1 (kind gifts of AL George, Northwestern University, Feinberg School of Medicine) and 1.2 µg pIRES2-EGFP plasmid (Clontech) encoding control or test peptides. For the experiments with the combination of peptides, COS-7 cells were co-transfected with 0.4 µg pRC-hNa~V~1.4, 0.4 µg pRC-hNa~V~ß1 and 0.6 µg of each of the two peptides encoding plasmid. For Na~V~Sp1 experiments, COS-7 cells were co-transfected with 0.8 µg pIRES2-EGFP-Na~V~Sp1 in which EGFP was removed and 1.2 µg pIRES2-EGFP plasmid encoding a control or a test peptide. Plasmid quantities were optimized to maximize the quantity of peptides, as assessed by the amount of fluorescence, and to keep current amplitudes in such a range that (i) undetectable currents were rare, and (ii) large currents inducing incorrect voltage-clamp were also rare. In pIRES2-EGFP plasmids, the second cassette (EGFP) is less expressed than the first cassette, guaranteeing high level of peptide expression in fluorescent cells^[@CR25]^. For experiments with mutant Na~V~Sp1, COS-7 cells were transfected with 2 µg pIRES2-EGFP-Na~V~Sp1. Cells were re-plated onto 35-mm Petri dishes the day after transfection for patch-clamp experiments.

Electrophysiology {#Sec12}
-----------------

The day after splitting, COS-7 cells were mounted on the stage of an inverted microscope and constantly perfused by a Tyrode solution (cf. below) at a rate of 1--3 ml/min. The bath temperature was maintained at 22.0 ± 2.0 °C. Stimulation and data recording were performed with pClamp 10, an A/D converter (Digidata 1440A) and an Axopatch 200B amplifier (all Molecular Devices). Patch pipettes (tip resistance: 1.5--2.2 MOhms) were pulled from soda lime glass capillaries (Kimble-Chase) and coated with dental wax to decrease capacitive currents. Currents were acquired in the whole-cell configuration, filtered at 10 kHz and recorded at a sampling rate of 20 kHz. Series resistance were compensated to 70--80%. To measure the Na~V~Sp1 currents, from a holding potential of −90 mV, the membrane was depolarized to 30 mV for 300 ms every 5 s. Na~V~Sp1 current was calculated after leak subtraction. To generate the activation curve, from a holding potential of −90 mV, the membrane was depolarized to values between −60 mV and +80 mV (+10 mV increment) for 300 ms, every 5 s. To measure the Na~V~1.4 current density after complete recovery from inactivation at −100 mV, a single step protocol was used to monitor current increase during recovery. From a holding potential of −100 mV, membrane was depolarized to 0 mV for 30 ms every 2 s. To generate the activation curve, from a holding potential of −100 mV, the membrane was depolarized to values between −70 mV and +50 mV (+5 mV increment) for 30 ms, every 2 s. As for Na~V~Sp1, Na~V~1.4 current was calculated after leak subtraction. To generate the inactivation curve, from a holding potential of −100 mV, membrane was depolarized to values between −110 mV and +25 mv (+5 mV increment) for 500 ms, followed by a 20-ms test pulse to 0 mV, every 4 s. Activation and inactivation curves were fitted by Boltzmann equations. G/V curves are obtained as follows: G~Na~ was calculated from G~Na~ = I~Na~/(V − V~rev~), where I~Na~ is the peak sodium current, V is the membrane potential and V~rev~ is the reversal potential estimated for each cell by linear regression of the linear rectification of I/V curve, when channels are fully activated. GV curves were subsequently obtained by dividing at each potential the peak current by the corresponding value of the linear regression curve.

Solutions {#Sec13}
---------

The cells were continuously superfused with a HEPES-buffered Tyrode solution containing (in mmol/L): NaCl 145, KCl 4, MgCl~2~ 1, CaCl~2~ 1, HEPES 5, glucose 5, pH adjusted to 7.4 with NaOH. Patch pipettes were filled with the following solution (in mmol/L): KCl 90, Kgluconate 45, NaCl 10, HEPES 10, pH adjusted to 7.2 with KOH.

Cell surface biotinylation assays {#Sec14}
---------------------------------

Surface biotinylation of transfected COS-7 cells (same condition as for patch-clamp experiments) was completed as described previously^[@CR50]^. Briefly, cells were incubated with 0.5 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (Pierce) in PBS, pH 7.4, for 30 min on ice. The biotinylation reaction was quenched with Tris-saline solution (10 mmol/L Tris, pH 7.4, 120 mmol/L NaCl), and detergent-soluble cell lysates were prepared. Biotinylated cell surface proteins were affinity-purified using Streptavidin-conjugated agarose beads (Pierce), and analyzed by western blot as described previously^[@CR50]^. Bands corresponding to hNa~V~1.4 were normalized to bands corresponding to TransR from the same sample. hNa~V~1.4 protein expression (total or biotinylated fraction) in cells co-transfected with test peptides is expressed relative to hNa~V~1.4 protein expression (total or biotinylated fraction) in cells co-transfected with Control 1 peptide-encoding plasmid. Antibodies used were anti-Na~V~PAN mouse monoclonal antibody (Sigma, S8809), mouse monoclonal antibody against the transferrin receptor (Invitrogen, 13-6890), and a mouse monoclonal antibody against GAPDH (Santa Cruz Biotechnology, sc-32233). Anti‐mouse horseradish peroxidase--conjugated secondary antibody was purchased from Santa Cruz Biotechnology.

Statistics {#Sec15}
----------

All data are expressed as mean ± sem. Statistical differences between samples were determined using Student's t-tests when data were normally distributed (biophysical parameters) and rank-sum tests (Mann Whitney test) when data were not normally distributed (current densities). A value of p \< 0.05 versus both controls was considered significant.
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